AK

Ashok Kumar Nayyar

Director Director DIN 00145785
DIN 00145785 First appointment Dec 1994 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 1994
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashok Kumar Nayyar

Data last updated:

Ashok Kumar Nayyar was a Director at Medicamen Biotech Limited (1994–2011) and Director at Ansulan Medi-Equip Private Limited (from 2003). The companies operate in Pharma.

DIN 00145785
Primary Designation Director
Industry Pharma
First Appointment 01 Dec 1994
Oldest Company Age 23 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medicamen Biotech Limited L74899DL1993PLC056594
Director01 Dec 19941993₹169 Cr (FY 2025)Active
Ansulan Medi-Equip Private Limited U51397DL2003PTC120576
Director25 Aug 20032003Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ansulan Medi-Equip Private Limited
Medicamen Biotech Limited
Premium access

Shareholding and investment profile for Ashok Kumar Nayyar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Kumar Nayyar

Ashok Kumar Nayyar was first appointed on 01 Dec 1994 as Director at Medicamen Biotech Limited. The most recent appointment on record is 25 Aug 2003 at Ansulan Medi-Equip Private Limited.

Ashok Kumar Nayyar held 2 earlier board appointments: Medicamen Biotech Limited (Director, 01 Dec 1994 to 24 Oct 2011); Ansulan Medi-Equip Private Limited (Director, from 25 Aug 2003).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available